Viewing Study NCT00287092


Ignite Creation Date: 2025-12-24 @ 3:53 PM
Ignite Modification Date: 2026-04-09 @ 11:21 AM
Study NCT ID: NCT00287092
Status: COMPLETED
Last Update Posted: 2015-01-07
First Post: 2006-02-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants
Sponsor: Sanofi Pasteur, a Sanofi Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module